ÆÑ¹«Ó¢ - ÖÆÒ©¼¼ÊõµÄ´«²¥Õß GMPÀíÂÛµÄʵ¼ùÕß

ËÑË÷
²é¿´: 11249|»Ø¸´: 18
ÊÕÆð×ó²à

ÃÀ¹úFDA¾¯¸æÐŹØÓÚ"²»ÔÊÐí"µÄ΢ÉúÎï(Objectionable Microorganism)

[¸´ÖÆÁ´½Ó]
Ò©Éú
·¢±íÓÚ 2012-11-27 22:07:50 | ÏÔʾȫ²¿Â¥²ã |ÔĶÁģʽ

»¶Ó­Äú×¢²áÆÑ¹«Ó¢

ÄúÐèÒª µÇ¼ ²Å¿ÉÒÔÏÂÔØ»ò²é¿´£¬Ã»ÓÐÕʺţ¿Á¢¼´×¢²á

x
±¾Ìû×îºóÓÉ kslam ÓÚ 2012-11-27 22:08 ±à¼­

[size=14.399999618530273px]ÓÐÒ»ÃÀ¹úFDA¾¯¸æÐŹØÓÚ"²»ÔÊÐí"µÄ΢ÉúÎï, FDA¶ÔÖÆÔìÉÌÒªÇóÊÇʲô?

[size=14.399999618530273px]¡¶Ëï×Ó¡¤Ä±¹¥Æª¡·ÖÐ˵£º¡°Öª¼ºÖª±Ë£¬°ÙÕ½²»´ù£»²»Öª±Ë¶øÖª¼º£¬Ò»Ê¤Ò»¸º"

²»ÔÊÐíµÄ΢ÉúÎï.pdf

239.03 KB, ÏÂÔØ´ÎÊý: 624

·¢±íÓÚ 2012-11-27 22:35:20 | ÏÔʾȫ²¿Â¥²ã
»Ø¸´

ʹÓõÀ¾ß ¾Ù±¨

ҩͽ
·¢±íÓÚ 2012-11-28 07:57:37 | ÏÔʾȫ²¿Â¥²ã
ÐÅÏ¢ÊÇÒ»ÖÖ¼°Ê±Óê.
»Ø¸´

ʹÓõÀ¾ß ¾Ù±¨

ҩͽ
·¢±íÓÚ 2012-11-28 11:07:49 | ÏÔʾȫ²¿Â¥²ã
Öª¼ºÖª±Ë~ѧϰһÏÂ
»Ø¸´

ʹÓõÀ¾ß ¾Ù±¨

ҩͽ
·¢±íÓÚ 2012-11-28 11:56:50 | ÏÔʾȫ²¿Â¥²ã
³¤ÖªÊ¶ÁË£¬Ð»Ð»À²
»Ø¸´

ʹÓõÀ¾ß ¾Ù±¨

ҩͽ
·¢±íÓÚ 2012-11-28 22:08:42 | ÏÔʾȫ²¿Â¥²ã
ʲô¶«Î÷ ѧϰÏ лл¥Ö÷
»Ø¸´

ʹÓõÀ¾ß ¾Ù±¨

ҩͽ
·¢±íÓÚ 2012-11-30 00:52:56 | ÏÔʾȫ²¿Â¥²ã
ÏÂÔØÑ§Ï°£¬Ð»Ð»Â¥Ö÷¡¤
»Ø¸´

ʹÓõÀ¾ß ¾Ù±¨

ҩͽ
·¢±íÓÚ 2012-11-30 20:24:59 | ÏÔʾȫ²¿Â¥²ã
    Á˽âÒ»ÏÂ
»Ø¸´

ʹÓõÀ¾ß ¾Ù±¨

ҩͽ
·¢±íÓÚ 2012-12-10 17:07:40 | ÏÔʾȫ²¿Â¥²ã
·­Òë³É¡°Óк¦Î¢ÉúÎ½ÏºÃ¡£ÒÔÏÂÊǾ¯¸æÐÅÔ­ÎÄ£¬´ó¼Ò¿ÉÒÔÑо¿ÌÖÂÛ
1. Your firm failed to establish and follow appropriate written procedures designed to prevent objectionable microorganisms in drug products not required to be sterile [21 C.F.R. ¡ì 211.113(a)].
The FDA collected samples of multiple lots of Zee Antiseptic Wipes and tested them. Several antiseptic wipes tested from two lots contained Burkholderia cepecia. The following is a summary of the results:

a. Lot JT1511-1 (manufactured in August, 2011):  B. cepacia,Staphylococcus intermedius, and Staphylococcus sciuri.

b. Lot JT23210 (manufactured in August, 2010): B. cepacia and Burkholderia pseudomallei.



We note that the label for Zee Antiseptic Wipes indicates that their intended use is to ¡°help prevent infection in minor cuts, scrapes and burns.¡±  The user is instructed to ¡°dab the wound with the wipe¡± and ¡°cover with a sterile bandage¡± [emphasis added]. We also note that your firm is not producing this product as sterile, but instead tests it for microbial contamination. It is essential that your firm¡¯s topical antiseptic drugs be produced in a manner that is appropriate in view of their intended use. The presence of organisms such as Burkholderia cepacia in a product intended to be used for wounds is unacceptable.

Please include in your response the source of the contamination, as well as a list of all products that are potentially impacted by the contamination. In addition, please include the in-process and finished product test results for all potentially impacted lots, distributed or undistributed. Include an explanation of the validated test methods that have been used to test your in-date marketed products for microbiological quality. Provide details on how your firm determined the identity of microbes in your non-sterile topical products, including whether only limited indicator organism testing, or routine speciation of bioburden, was performed when testing each batch for absence of objectionable microorganisms.  

We are concerned about your firm¡¯s failure to assure appropriate microbial quality of batches shipped to the US, and the insufficient basis for your actions thus far to address the potential patient hazard posed by your manufacturing practices. Provide a risk assessment of all products that have been released to the market and an action plan with a strong scientific rationale that supports your plans regarding all potentially impacted lots, both distributed and undistributed.
»Ø¸´

ʹÓõÀ¾ß ¾Ù±¨

Ò©Éú
 Â¥Ö÷| ·¢±íÓÚ 2012-12-10 17:31:32 | ÏÔʾȫ²¿Â¥²ã
GmpForEver ·¢±íÓÚ 2012-12-10 17:07
·­Òë³É¡°Óк¦Î¢ÉúÎ½ÏºÃ¡£ÒÔÏÂÊǾ¯¸æÐÅÔ­ÎÄ£¬´ó¼Ò¿ÉÒÔÑо¿ÌÖÂÛ
1. Your firm failed to establish and f ...

FDAÑ¡ÔñÁËÕâÊõÓï"objectionable microorganism" ÊǼøÓÚijЩ΢ÉúÎïÈçÀà±Ç¾Ò²®¿ËÊϾú, Ñó´Ð²®¿Ë»ô¶ûµÂ¾úÖ»ÄÜÓ°ÏìÃâÒß¹¦Äܵ͵IJ¡ÈË, ¶ø²»»á¶Ô½¡¿µµÄÈËÓк¦. Òò´Ë£¬FDA²»½«ÆäÃüÃûΪ"harmful microorganism" ¡°Óк¦Î¢ÉúÎ.
»Ø¸´

ʹÓõÀ¾ß ¾Ù±¨

·¢±íÓÚ 2012-12-10 17:36:16 | ÏÔʾȫ²¿Â¥²ã
Ó¢ÎĵÄÒ²µÃºÃºÃ¿´¿´£¬Ñ§Ñ§
»Ø¸´

ʹÓõÀ¾ß ¾Ù±¨

ҩͽ
·¢±íÓÚ 2013-1-8 19:34:15 | ÏÔʾȫ²¿Â¥²ã
лл·ÖÏí£¡£¡£¡£¡£¡£¡£¡£¡£¡£¡£¡£¡£¡£¡
»Ø¸´

ʹÓõÀ¾ß ¾Ù±¨

·¢±íÓÚ 2016-7-27 09:44:08 | ÏÔʾȫ²¿Â¥²ã
лл·ÖÏí¡£
»Ø¸´

ʹÓõÀ¾ß ¾Ù±¨

Ò©Ê¿
·¢±íÓÚ 2017-8-5 16:47:08 | ÏÔʾȫ²¿Â¥²ã
Õâ¸ö¿Î¼þÍÆ¼öһϣ¡Determination of Objectionable Microorganisms

Determination of Objectionable Microorganisms.pdf

1.06 MB, ÏÂÔØ´ÎÊý: 125

»Ø¸´

ʹÓõÀ¾ß ¾Ù±¨

Ò©Ê¿
·¢±íÓÚ 2017-8-5 16:48:13 | ÏÔʾȫ²¿Â¥²ã
Bad Bug Book (Second Edition)
Foodborne Pathogenic Microorganisms and Natural Toxins Handbook
https://www.fda.gov/Food/Foodbor ... Book/ucm2006773.htm
»Ø¸´

ʹÓõÀ¾ß ¾Ù±¨

Ò©Ê¿
·¢±íÓÚ 2017-8-5 18:14:20 | ÏÔʾȫ²¿Â¥²ã
kslam ·¢±íÓÚ 2012-12-10 17:31
FDAÑ¡ÔñÁËÕâÊõÓï"objectionable microorganism" ÊǼøÓÚijЩ΢ÉúÎïÈçÀà±Ç¾Ò²®¿ËÊϾú, Ñó´Ð²®¿Ë»ô¶ûµÂ¾úÖ» ...

ȷʵÕâÑùµÄ˵·¨£º
¡ì211.113   Control of microbiological contamination.

(a) Appropriate written procedures, designed to prevent objectionable microorganisms in drug products not required to be sterile, shall be established and followed.

304. Several comments requested clarification of the term "objectionable microorganisms" as used in 211.113(a) or suggested alternative descriptions of objectionable microorganisms such as harmful or pathogenic and fecal indicator microorganisms.     The Commissioner deliberately chose the word "objectionable" as the appropriate modifier for the term "microorganisms" in this paragraph to cover a number of circumstances.  Microorganisms could be objectionable by virtue of their total numbers or their detrimental effect on the product or by their potential for causing illness in the persons ingesting them.  A definition of the term is not practical in the regulations, however, because the objectionable nature of a microorganism may develop only in relation to the unique circumstances of a particular formulation, a particular ingredient, a particular method of manufacture, or the conditions found at a particular firm.  The Commissioner believes that the use of the word "objectionable" in a very broad sense is a more practical means of expressing the kind of control he intends.
»Ø¸´

ʹÓõÀ¾ß ¾Ù±¨

Ò©Ê¿
·¢±íÓÚ 2017-8-5 18:15:46 | ÏÔʾȫ²¿Â¥²ã
±¾Ìû×îºóÓÉ beiwei5du ÓÚ 2017-8-5 18:17 ±à¼­

ÏÖÔÚ¹úÄÚ£¬Õë¶ÔÓÚ·ÇÎÞ¾úÔ­ÁÏÒ©»òÖÆ¼Á£¬ÔÚobjectionable microorganismsÕâ·½Ãæ»¹±È½ÏÈõ°É£¡ÌرðÐèҪרÃŵÄ΢ÉúÎïѧ¼Ò¸ù¾Ý¾ßÌåµÄ²úÆ·Çé¿ö½¨Á¢ÊÊÒ˵Äobjectionable microorganisms list.
»Ø¸´

ʹÓõÀ¾ß ¾Ù±¨

·¢±íÓÚ 2019-8-1 10:23:53 | ÏÔʾȫ²¿Â¥²ã
ÏÂÔØÑ§Ï°£¬Ñ§Ï°£¬Ñ§Ï°£¡
»Ø¸´

ʹÓõÀ¾ß ¾Ù±¨

Ò©Íõ
·¢±íÓÚ 2022-8-6 22:11:43 | ÏÔʾȫ²¿Â¥²ã
лл·ÖÏí£¡£¡£¡
»Ø¸´

ʹÓõÀ¾ß ¾Ù±¨

ÄúÐèÒªµÇ¼ºó²Å¿ÉÒÔ»ØÌû µÇ¼ | Á¢¼´×¢²á

±¾°æ»ý·Ö¹æÔò

×·¢ÌûÉùÃ÷
1¡¢±¾Õ¾Îª¼¼Êõ½»Á÷ÂÛ̳£¬·¢ÌûµÄÄÚÈݾßÓл¥¶¯ÊôÐÔ¡£ÄúÔÚ±¾Õ¾·¢²¼µÄÄÚÈÝ£º
¢ÙÔÚÎÞÈ˻ظ´µÄÇé¿öÏ£¬¿ÉÒÔͨ¹ý×ÔÖúɾÌû¹¦ÄÜËæÊ±É¾³ý£¨×ÔÖúɾÌû¹¦ÄÜ¹Ø±ÕÆÚ¼ä£¬¿ÉÒÔÁªÏµ¹ÜÀíԱ΢ÐÅ£º8542508 ´¦Àí¡££©
¢ÚÔÚÓÐÈ˻ظ´ºÍÌÖÂÛµÄÇé¿öÏ£¬Ö÷ÌâÌûºÍ»Ø¸´ÄÚÈÝÒѹ¹³ÉÒ»¸ö²»¿É·Ö¸îµÄÕûÌ壬Äú½«²»ÄÜÖ±½Óɾ³ý¸ÃÌû¡£
2¡¢½ûÖ¹·¢²¼ÈκÎÉæÕþ¡¢Éæ»Æ¶Ä¶¾¼°ÆäËûÎ¥·´¹ú¼ÒÏà¹Ø·¨ÂÉ¡¢·¨¹æ¡¢¼°±¾Õ¾°æ¹æµÄÄÚÈÝ£¬ÏêÇéÇë²ÎÔÄ¡¶ÆÑ¹«Ó¢ÂÛ̳×Ü°æ¹æ¡·¡£
3¡¢ÄúÔÚ±¾Õ¾·¢±í¡¢×ªÔصÄÈκÎ×÷Æ·½ö´ú±íÄú¸öÈ˹۵㣬²»´ú±í±¾Õ¾¹Ûµã¡£²»ÒªµÁÓÃÓаæÈ¨ÒªÇóµÄ×÷Æ·£¬×ªÌùÇë×¢Ã÷À´Ô´£¬·ñÔòÎÄÔð×Ô¸º¡£
4¡¢ÇëÈÏÕæÔĶÁÉÏÊöÌõ¿î£¬Äú·¢Ìû¼´´ú±í½ÓÊÜÉÏÊöÌõ¿î¡£

QQ|ÊÖ»ú°æ|ÆÑ¹«Ó¢|ouryao|ÆÑ¹«Ó¢ ( ¾©ICP±¸14042168ºÅ-1 )  ÔöÖµµçÐÅÒµÎñ¾­ÓªÐí¿ÉÖ¤±àºÅ£º¾©B2-20243455  »¥ÁªÍøÒ©Æ·ÐÅÏ¢·þÎñ×ʸñÖ¤Êé±àºÅ£º(¾©)-·Ç¾­ÓªÐÔ-2024-0033

GMT+8, 2025-9-22 04:50

Powered by Discuz! X3.4

Copyright © 2001-2020, Tencent Cloud.

ÉùÃ÷£ºÆÑ¹«Ó¢ÍøÕ¾ËùÉæ¼°µÄÔ­´´ÎÄÕ¡¢ÎÄ×ÖÄÚÈÝ¡¢ÊÓÆµÍ¼Æ¬¼°Ê×·¢×ÊÁÏ£¬°æÈ¨¹é×÷Õß¼°ÆÑ¹«Ó¢ÍøÕ¾ËùÓУ¬×ªÔØÒªÔÚÏÔÖøÎ»ÖñêÃ÷À´Ô´¡°ÆÑ¹«Ó¢¡±£»½ûÖ¹ÈκÎÐÎʽµÄÉÌÒµÓÃ;¡£Î¥·´ÉÏÊöÉùÃ÷µÄ£¬±¾Õ¾¼°×÷Õß½«×·¾¿·¨ÂÉÔðÈΡ£
¿ìËٻظ´ ·µ»Ø¶¥²¿ ·µ»ØÁбí